NMN (Nicotinamide Mononucleotide): NAD+ Precursor, Longevity, And Exercise

NMN is one of the most hyped longevity supplements, but the regulatory status and human evidence are more complicated than marketing suggests.

In this post, we will discuss what NMN does, how it compares to NR and niacin, what human trials actually show, and how to think about the safety and conflicts of interest.

---

What Is NMN

Nicotinamide mononucleotide (NMN) is a direct precursor to nicotinamide adenine dinucleotide (NAD+). R

NAD+ is a coenzyme found in all living cells and is essential for energy metabolism, DNA repair, and the regulation of circadian rhythms and longevity pathways. R

NMN is marketed as an anti-aging supplement because NAD+ levels decline with age. R

NAD+ Biology

NAD+ is a critical cofactor for mitochondrial function, sirtuin activity, and PARP-mediated DNA repair. R

NAD+ levels naturally decline with age due to increased consumption by enzymes like PARPs and CD38, and reduced biosynthetic capacity. R

Supplementation aims to boost systemic NAD+ levels to counteract age-related mitochondrial dysfunction and physiological decline. R

NMN Vs NR Vs Niacin

NMN

NMN is one step closer to NAD+ than NR. R

It is converted to NAD+ via the enzyme NMNAT. R

NR (Nicotinamide Riboside)

NR must be converted to NMN before becoming NAD+. R

It has a longer track record of safety data in human trials. R

Niacin

Niacin is a budget-friendly, traditional form of vitamin B3. R

It raises NAD+ but often causes flushing and can affect liver enzymes and lipid profiles. R

Human Trials

Metabolism

A 2021 trial found that NMN supplementation improved insulin sensitivity in prediabetic women. R

This was one of the first major human trials showing a metabolic benefit. R

Exercise

A 2022 trial found that NMN improved aerobic capacity (VO2 max) in amateur runners. R

Another study showed increased walking distance in middle-aged adults. R

Muscle Strength

Results on absolute muscle strength have been mixed. R

Some trials show benefits in muscle function, while others do not. R

Safety And Regulatory Status

Most clinical trials report NMN as well-tolerated with no significant adverse events at doses up to 900-1000 mg per day for 8-12 weeks. R

The US FDA designated NMN as an investigational new drug (IND) in late 2022, which initially restricted its sale as a dietary supplement. R

However, this ruling was reversed in 2025, and NMN is currently lawful to market as a dietary supplement. R

Conflicts Of Interest

The NAD+ supplement space is heavily influenced by commercial interests. R

A significant portion of published research is sponsored by manufacturers or involves authors with financial ties to supplement companies. R

When evaluating research, prioritize meta-analyses or trials that explicitly declare no conflict of interest. R

Dosing And Forms

Typical doses in human trials range from 300-900 mg per day. R

Oral capsules are the standard delivery method used in clinical trials. R

Sublingual forms are popular in the consumer market, but rigorous human trials comparing sublingual vs oral bioavailability are lacking. R

Mechanisms Of Action

Simple:

NMN is converted into NAD+, a cofactor for energy production and DNA repair. Higher NAD+ may support mitochondrial function and sirtuin activity. Human benefits appear strongest for metabolism and exercise capacity.

Advanced:

NMNAT conversion. NMN is phosphorylated by nicotinamide mononucleotide adenylyltransferase (NMNAT) to form NAD+. R Sirtuin activation. NAD+ is a cofactor for sirtuins, which regulate metabolism, DNA repair, and stress resistance. R PARP activity. NAD+ is consumed by PARPs during DNA repair; high DNA damage may divert NAD+ away from sirtuins and mitochondria. R CD38 and aging. CD38 is a NADase that increases with age and degrades NAD+; some researchers argue that inhibiting CD38 may be as important as boosting precursors. R

Genetics

NMNAT1 / NMNAT2 / NMNAT3

NMNAT enzymes convert NMN to NAD+. R

Genetic variation may influence how efficiently NMN is converted. R

CD38

CD38 encodes a NADase that degrades NAD+. R

Higher CD38 expression with age may contribute to NAD+ decline. R

NNMT

NNMT metabolizes nicotinamide and may influence methyl donor status. R

Excessive nicotinamide intake may increase NNMT activity, potentially depleting methyl groups. R

More Research

Longevity in animals. NMN extends lifespan and improves healthspan in some mouse models, but human longevity data do not exist. R Cognitive function. Preliminary studies explore NMN for cognitive decline, but robust human trials are lacking. R Sleep and circadian rhythm. NAD+ supports circadian clock function, and some users report improved sleep, though trial evidence is limited. R

• Testing. For biomarker testing I use the Comprehensive Metabolic Panel and Mitochondrial Panel to assess NAD+ related metabolic status.